Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1).

Phillips LS, Weintraub WS, Ziemer DC, Kolm P, Foster JK, Vaccarino V, Rhee MK, Budhwani RK, Caudle JM. All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1). Diabetes Care 2006 Jun;29(6):1405-7.

PubMed ID: 16732034
Public Release Type: Journal
Publication Year: 2006
Affiliation: Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine, Emory University Hospital, 1364 Clifton Road, Atlanta, GA 30322, USA. medlsp@emory.edu
DOI: https://doi.org/10.2337/dc06-0242
Authors: Rhee MK, Budhwani RK, Caudle JM, Phillips LS, Weintraub WS, Ziemer DC, Kolm P, Foster JK, Vaccarino V
Studies: Screening for Impaired Glucose Tolerance

Home chevron_right Publications chevron_right All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1).

All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1).

Abstract